The crisis in Cochrane: Evidence Debased Medicine

Area of Science:

• Medical research integrity
• Evidence-based medicine
• Public health policy

Background:

• The Cochrane Collaboration, founded in 1993, aimed to provide high-quality medical evidence.
• A current crisis involves founder dismissal and clinical trial data access issues.
• This crisis occurs amidst concerns about declining life expectancies and medication safety.

Purpose of the Study:

• To examine the Cochrane Collaboration's crisis.
• To contextualize the crisis within the negative impacts of pediatric depression medications.
• To highlight the consequences of suppressed adverse findings from clinical trials.

Main Methods:

• Literature review and critical analysis of the Cochrane Collaboration's current situation.
• Examination of case studies related to pediatric depression medication.
• Analysis of the role of suppressed clinical trial data in adverse health outcomes.

Main Results:

• The crisis at the Cochrane Collaboration raises questions about the reliability of medical evidence.
• Suppression of adverse findings in pediatric depression trials has led to harmful effects on children's health.
• Lack of transparency in clinical trial data hinders accurate medical assessments.

Conclusions:

• The ongoing crisis within the Cochrane Collaboration poses significant risks to public health and medical trust.
• Urgent reforms are needed to ensure transparency and accessibility of clinical trial data.
• Protecting patient safety, especially in vulnerable populations like children, must be paramount.